161875-97-4 - Names and Identifiers
161875-97-4 - Physico-chemical Properties
Molecular Formula | C31H43N7O6
|
Molar Mass | 609.72 |
Density | 1.30±0.1 g/cm3(Predicted) |
Melting Point | 183-185°C |
Boling Point | 1068.3±65.0 °C(Predicted) |
Specific Rotation(α) | -73.4 (c, 0.4 in MeOH) |
Solubility | Soluble in methanol, slightly soluble in ethyl acetate |
Appearance | White powder |
pKa | 13.29±0.70(Predicted) |
Storage Condition | 2-8℃ |
161875-97-4 - Reference
Reference Show more | 1. [IF=4.556] Xian-Guo Zou et al."Comparisons of proximate compositions, fatty acids profile and micronutrients between fiber and oil flaxseeds (Linum usitatissimum L.)."J Food Compos Anal. 2017 Sep;62:168 2. [IF=4.556] Junpeng Zeng et al."The comparative analysis of different oil extraction methods based on the quality of flaxseed oil."J Food Compos Anal. 2021 Dec;:104373 |
161875-97-4 - Introduction
Segettalin A (segettalin A) is A natural product with the formula C57H75N9O16. It is found mainly in the roots of this perennial plant, the King (Ranunculus muricatus).
Segetalin A is A cyclic peptide, which contains multiple amino acid residues and forms A ring structure in the molecule. It has antibacterial, antiviral and antitumor activities. Studies have shown that Segetalin A has an inhibitory effect on the growth of A variety of bacteria, viruses and cancer cells, and has potential anti-tumor activity against liver cancer, ovarian cancer and colon cancer.
About the preparation method, the more commonly used method is to extract from The King of the plant. The extracted mixture was purified and separated by chromatographic techniques to obtain pure Segetalin A.
When using Segetalin A, you should pay attention to its safety. Although Segetalin A has some medicinal potential, its toxicity and side effects still require further study and evaluation. When using, it is necessary to make appropriate dose and use adjustments to avoid excessive use and improper use. In addition, for pregnant women, lactating women and children and other special groups, should avoid the use of Segetalin A, so as to avoid adverse reactions.
Last Update:2024-04-10 22:29:15